Cargando…

A Five-Year Analysis of Industry Payments to Sleep Neurologists From 2014 Through 2018

Background and objectives  Sleep medicine has been one of the fastest-growing medical fields in recent years. The industry plays a big role in developing new medications and devices for both diagnosis and treatment of sleep-related problems. We analyzed payments made by industry to physicians from 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Dandu, Vasuki, Siddamreddy, Suman, Thombre, Vaishali, Veerapaneni, Karthika Durga, Yadala, Sisira, Sheng, Sen, Mahashabde, Ruchira, Harada, Yohei, Kapoor, Nidhi, Onteddu, Sanjeeva, Nalleballe, Krishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581217/
https://www.ncbi.nlm.nih.gov/pubmed/33110732
http://dx.doi.org/10.7759/cureus.10597
_version_ 1783598932160413696
author Dandu, Vasuki
Siddamreddy, Suman
Thombre, Vaishali
Veerapaneni, Karthika Durga
Yadala, Sisira
Sheng, Sen
Mahashabde, Ruchira
Harada, Yohei
Kapoor, Nidhi
Onteddu, Sanjeeva
Nalleballe, Krishna
author_facet Dandu, Vasuki
Siddamreddy, Suman
Thombre, Vaishali
Veerapaneni, Karthika Durga
Yadala, Sisira
Sheng, Sen
Mahashabde, Ruchira
Harada, Yohei
Kapoor, Nidhi
Onteddu, Sanjeeva
Nalleballe, Krishna
author_sort Dandu, Vasuki
collection PubMed
description Background and objectives  Sleep medicine has been one of the fastest-growing medical fields in recent years. The industry plays a big role in developing new medications and devices for both diagnosis and treatment of sleep-related problems. We analyzed payments made by industry to physicians from 2014 through 2018 based on the Open Payments Program data. Methods Centers for Medicare and Medicaid Services Open Payment Program and American Board of Psychiatry and Neurology databases were explored to elicit financial relationships between industry and sleep neurologists. Results Payments made by industry to sleep neurologists have been steadily increasing from 2014 through 2018. Approximately 16% to 22% of sleep certified neurologists received payments from industry during the study period. Interestingly, the payments made to the top 10% of the sleep physicians contributed approximately 85% to 96% of the total payments. The top two categories to which the highest payments were made were compensation for services and royalty and/or licensing fees. Silenor® (doxepin), Xyrem® (sodium oxybate), Aptiom® (eslicarbazepine acetate), Belsomra® (suvorexant), and Fycompa® (perampanel) were most of the drugs, which made the highest payments, that got approved by the Food and Drug Administration in the last decade. Conclusions  It seems that the industry is spending significant amounts of money in educating the physicians and in marketing the newer drugs. This analysis of the data on payments from industry is very useful in identifying any potential conflicts of interest from physicians. Further analyses are needed to study the trends of physician practice behavior and decision making.
format Online
Article
Text
id pubmed-7581217
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-75812172020-10-26 A Five-Year Analysis of Industry Payments to Sleep Neurologists From 2014 Through 2018 Dandu, Vasuki Siddamreddy, Suman Thombre, Vaishali Veerapaneni, Karthika Durga Yadala, Sisira Sheng, Sen Mahashabde, Ruchira Harada, Yohei Kapoor, Nidhi Onteddu, Sanjeeva Nalleballe, Krishna Cureus Internal Medicine Background and objectives  Sleep medicine has been one of the fastest-growing medical fields in recent years. The industry plays a big role in developing new medications and devices for both diagnosis and treatment of sleep-related problems. We analyzed payments made by industry to physicians from 2014 through 2018 based on the Open Payments Program data. Methods Centers for Medicare and Medicaid Services Open Payment Program and American Board of Psychiatry and Neurology databases were explored to elicit financial relationships between industry and sleep neurologists. Results Payments made by industry to sleep neurologists have been steadily increasing from 2014 through 2018. Approximately 16% to 22% of sleep certified neurologists received payments from industry during the study period. Interestingly, the payments made to the top 10% of the sleep physicians contributed approximately 85% to 96% of the total payments. The top two categories to which the highest payments were made were compensation for services and royalty and/or licensing fees. Silenor® (doxepin), Xyrem® (sodium oxybate), Aptiom® (eslicarbazepine acetate), Belsomra® (suvorexant), and Fycompa® (perampanel) were most of the drugs, which made the highest payments, that got approved by the Food and Drug Administration in the last decade. Conclusions  It seems that the industry is spending significant amounts of money in educating the physicians and in marketing the newer drugs. This analysis of the data on payments from industry is very useful in identifying any potential conflicts of interest from physicians. Further analyses are needed to study the trends of physician practice behavior and decision making. Cureus 2020-09-22 /pmc/articles/PMC7581217/ /pubmed/33110732 http://dx.doi.org/10.7759/cureus.10597 Text en Copyright © 2020, Dandu et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Dandu, Vasuki
Siddamreddy, Suman
Thombre, Vaishali
Veerapaneni, Karthika Durga
Yadala, Sisira
Sheng, Sen
Mahashabde, Ruchira
Harada, Yohei
Kapoor, Nidhi
Onteddu, Sanjeeva
Nalleballe, Krishna
A Five-Year Analysis of Industry Payments to Sleep Neurologists From 2014 Through 2018
title A Five-Year Analysis of Industry Payments to Sleep Neurologists From 2014 Through 2018
title_full A Five-Year Analysis of Industry Payments to Sleep Neurologists From 2014 Through 2018
title_fullStr A Five-Year Analysis of Industry Payments to Sleep Neurologists From 2014 Through 2018
title_full_unstemmed A Five-Year Analysis of Industry Payments to Sleep Neurologists From 2014 Through 2018
title_short A Five-Year Analysis of Industry Payments to Sleep Neurologists From 2014 Through 2018
title_sort five-year analysis of industry payments to sleep neurologists from 2014 through 2018
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581217/
https://www.ncbi.nlm.nih.gov/pubmed/33110732
http://dx.doi.org/10.7759/cureus.10597
work_keys_str_mv AT danduvasuki afiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT siddamreddysuman afiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT thombrevaishali afiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT veerapanenikarthikadurga afiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT yadalasisira afiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT shengsen afiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT mahashabderuchira afiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT haradayohei afiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT kapoornidhi afiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT onteddusanjeeva afiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT nalleballekrishna afiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT danduvasuki fiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT siddamreddysuman fiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT thombrevaishali fiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT veerapanenikarthikadurga fiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT yadalasisira fiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT shengsen fiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT mahashabderuchira fiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT haradayohei fiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT kapoornidhi fiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT onteddusanjeeva fiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018
AT nalleballekrishna fiveyearanalysisofindustrypaymentstosleepneurologistsfrom2014through2018